Difference between revisions of "About-cancer/treatment/drugs/pancreatic"
(Created page with "== Drugs Approved for Pancreatic Cancer == This page lists cancer drugs approved by the Food and Drug Administration (FDA) for pancreatic cancer. The list includes generic na...") |
(Marked this version for translation) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | == Drugs Approved for Pancreatic Cancer == | + | <languages/> |
| + | <translate> | ||
| + | == Drugs Approved for Pancreatic Cancer == <!--T:1--> | ||
| + | <!--T:2--> | ||
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for pancreatic cancer. The list includes generic names and brand names.This page also lists common drug combinations used in pancreatic cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used. | This page lists cancer drugs approved by the Food and Drug Administration (FDA) for pancreatic cancer. The list includes generic names and brand names.This page also lists common drug combinations used in pancreatic cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used. | ||
| + | <!--T:3--> | ||
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in pancreatic cancer that are not listed here. | The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in pancreatic cancer that are not listed here. | ||
| − | === Drugs Approved for Pancreatic Cancer === | + | === Drugs Approved for Pancreatic Cancer === <!--T:4--> |
| + | <!--T:5--> | ||
Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation) | Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation) | ||
| + | <!--T:6--> | ||
Afinitor (Everolimus) | Afinitor (Everolimus) | ||
| + | <!--T:7--> | ||
Erlotinib Hydrochloride | Erlotinib Hydrochloride | ||
| + | <!--T:8--> | ||
Everolimus | Everolimus | ||
| + | <!--T:9--> | ||
5-FU (Fluorouracil Injection) | 5-FU (Fluorouracil Injection) | ||
| + | <!--T:10--> | ||
Fluorouracil Injection | Fluorouracil Injection | ||
| + | <!--T:11--> | ||
Gemcitabine Hydrochloride | Gemcitabine Hydrochloride | ||
| + | <!--T:12--> | ||
Gemzar (Gemcitabine Hydrochloride) | Gemzar (Gemcitabine Hydrochloride) | ||
| + | <!--T:13--> | ||
Irinotecan Hydrochloride Liposome | Irinotecan Hydrochloride Liposome | ||
| + | <!--T:14--> | ||
Mitomycin C | Mitomycin C | ||
| + | <!--T:15--> | ||
Onivyde (Irinotecan Hydrochloride Liposome) | Onivyde (Irinotecan Hydrochloride Liposome) | ||
| + | <!--T:16--> | ||
Paclitaxel Albumin-stabilized Nanoparticle Formulation | Paclitaxel Albumin-stabilized Nanoparticle Formulation | ||
| + | <!--T:17--> | ||
Sunitinib Malate | Sunitinib Malate | ||
| + | <!--T:18--> | ||
Sutent (Sunitinib Malate) | Sutent (Sunitinib Malate) | ||
| + | <!--T:19--> | ||
Tarceva (Erlotinib Hydrochloride) | Tarceva (Erlotinib Hydrochloride) | ||
| − | === Drug Combinations Used in Pancreatic Cancer === | + | === Drug Combinations Used in Pancreatic Cancer === <!--T:20--> |
| + | <!--T:21--> | ||
FOLFIRINOX | FOLFIRINOX | ||
| + | <!--T:22--> | ||
GEMCITABINE-CISPLATIN | GEMCITABINE-CISPLATIN | ||
| + | <!--T:23--> | ||
GEMCITABINE-OXALIPLATIN | GEMCITABINE-OXALIPLATIN | ||
| + | <!--T:24--> | ||
OFF | OFF | ||
| − | === Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors === | + | === Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors === <!--T:25--> |
| + | <!--T:26--> | ||
Afinitor Disperz (Everolimus) | Afinitor Disperz (Everolimus) | ||
| + | <!--T:27--> | ||
Lanreotide Acetate | Lanreotide Acetate | ||
| + | <!--T:28--> | ||
Lutathera (Lutetium Lu 177-Dotatate) | Lutathera (Lutetium Lu 177-Dotatate) | ||
| + | <!--T:29--> | ||
Lutetium Lu 177-Dotatate | Lutetium Lu 177-Dotatate | ||
| + | <!--T:30--> | ||
Somatuline Depot (Lanreotide Acetate) | Somatuline Depot (Lanreotide Acetate) | ||
| + | </translate> | ||
Latest revision as of 21:38, 29 October 2019
Contents
Drugs Approved for Pancreatic Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for pancreatic cancer. The list includes generic names and brand names.This page also lists common drug combinations used in pancreatic cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in pancreatic cancer that are not listed here.
Drugs Approved for Pancreatic Cancer
Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
Afinitor (Everolimus)
Erlotinib Hydrochloride
Everolimus
5-FU (Fluorouracil Injection)
Fluorouracil Injection
Gemcitabine Hydrochloride
Gemzar (Gemcitabine Hydrochloride)
Irinotecan Hydrochloride Liposome
Mitomycin C
Onivyde (Irinotecan Hydrochloride Liposome)
Paclitaxel Albumin-stabilized Nanoparticle Formulation
Sunitinib Malate
Sutent (Sunitinib Malate)
Tarceva (Erlotinib Hydrochloride)
Drug Combinations Used in Pancreatic Cancer
FOLFIRINOX
GEMCITABINE-CISPLATIN
GEMCITABINE-OXALIPLATIN
OFF
Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors
Afinitor Disperz (Everolimus)
Lanreotide Acetate
Lutathera (Lutetium Lu 177-Dotatate)
Lutetium Lu 177-Dotatate
Somatuline Depot (Lanreotide Acetate)
